LIFE SCIENCE INSTRUMENTATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Growing Adoption of Technological Advancements

Another important factor contributing to the positive outlook of the life science instrumentation market is the rising adoption of new technologies across various application areas. Continuous innovation is taking place in the development of instruments that are more efficient, higher-throughput, miniaturized and capable of multi-modal analysis. Emerging technologies such as automation, machine learning, artificial intelligence, robotics, next-generation sequencing and lab-on-a-chip are tremendously enhancing the capabilities of existing instruments. Transition to automated platforms is helping streamline complex workflow in spaces like proteomics, genomics and cell biology research. Use of robotics is minimizing manual errors and improving reproducibility. Lab automation is drastically reducing processing time and sample volumes required. Life science researchers and companies are rapidly embracing these technological breakthroughs to refine older techniques, develop novel methods and elevate the pace of scientific discovery. Affordable prices of some advanced instruments are also encouraging their wider acceptance. For instance, DNA sequencing machines have become more widespread with advances lowering costs 100 to 1,000-fold compared to previous versions

• Agilent Technologies
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Waters Corporation
• GE Healthcare
• Shimadzu Corporation
• PerkinElmer Inc.
• Illumina, Inc.
• Qiagen N.V.
• Merck KGaA
• Abbott Laboratories
• Hitachi High-Technologies Corporation
• Roche Diagnostics
• Beckman Coulter, Inc.
• Eppendorf AG